Aspen Neuroscience Appoints Jeff Boerneke as General Counsel and Secretary

Experienced biotech legal executive strengthens leadership team as Aspen advances clinical development and prepares for Phase 3 growth SAN DIEGO, June 11, 2026 /PRNewswire/ -- Aspen Neuroscience, Inc., a clinical-stage regenerative medicine biotechnology company developing personalized,...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.